Q3 2022 Mersana Therapeutics Inc Earnings Call Transcript
Good morning. And welcome to the Mersana Therapeutics Third Quarter 2022 Conference Call and Webcast. (Operator Instructions).
I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed.
Good morning, everyone. Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements include, but are not limited to, those related to the therapeutic potential of our product candidates, and the potential of our platforms, business strategy, clinical trial design, initiation, execution and data releases, regulatory plans and objectives, commercial opportunities, collaborations and potential associated payments; operating expenses and cash runway.
Each of these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |